Skip to main content

Advertisement

Log in

Parathyroid adenoma upstaging the lung cancer

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Mediastinal staging of NSCLC with noninvasive methods such as PET/CT can be misleading when a mediastinal disease accompany. Histopathologic confirmation should be made before any treatment plan. Herein, we presented a case of parathyroid adenoma upstaging the lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Moloney F, Ryan D, McCarthy J. Increasing the accuracy of 18F-FDG PET/CT interpretation of mildly positive mediastinal nodes in the staging of non-small cell lung cancer. Eur J Radiol. 2014;83(5):843–7.

    Article  CAS  PubMed  Google Scholar 

  2. Li S, Zheng Q, Ma Y. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of 18F-FDG PET/CT. PLoS One. 2013;8(10):e78552.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Iskender I, Kadioglu SZ, Cosgun T. False positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer. Eur J Cardiothorac Surg. 2012;41(4):874–9.

    Article  PubMed  Google Scholar 

  4. De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98.

    Article  PubMed  Google Scholar 

  5. Yoshino I, Yokoyama H, Yano T. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg. 1996;62(4):1021–5.

    Article  CAS  PubMed  Google Scholar 

  6. Gilmore DM, Khullar OV, Jaklitsch MT. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. J Thorac Cardiovasc Surg. 2013;146(3):562–70.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Chun IK, Cheon GJ, Paeng JC. Detection and characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between 11C-Methionine PET/CT and 99m-Sestamibi scintigraphy. Nucl Med Mol İmaging. 2013;47(3):166–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Guy MS, Jakob C, McDonald SD. 18F-FDG PET/CT metabolic variability in functioning oncocytic parathyroid adenoma with Brown tumors. Clin Nucl Med. 2014;39(4):393–5.

    Article  PubMed  Google Scholar 

  9. Evangelista L, Cervino AR, Gregianin M. FDG-PET/CT visualises a case of primary hyperparathyroidism in patient with GIST. Minerva Endocrinol. 2010;35(3):193–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kursat Okuyucu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okuyucu, K., Kavakli, K., Ozaydın, S. et al. Parathyroid adenoma upstaging the lung cancer. Ann Nucl Med 29, 371–374 (2015). https://doi.org/10.1007/s12149-015-0946-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-015-0946-x

Keywords

Navigation